Sort
30,917 grants matching “tumor microenvironment”
Angiogenesis and Tumor Growth
$603,258Giovanna Tosato · Division Of Clinical Sciences - Nci · ZIA · FY2010 · CA
Re-wiring PDAC Tumor Immunity Through Dendritic Cells
$603,069David G Denardo · Washington University · R01 · FY2023 · CA
Immune cell control of ovarian cancer
$603,049Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Disrupting the immune and drug-privileged microenvironment in pancreas cancer
$602,955Sunil R Hingorani · Fred Hutchinson Cancer Research Center · U01 · FY2020 · CA
Ovarian Cancer Epigenetics, Immunity and Therapy
$602,952Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2019 · CA
Novel immunotherapies using optimized tumor cell-penetrating antibodies
$602,881Jose R Conejo-Garcia · Duke University · R01 · FY2025 · CA
A novel preclinical model of spontaneous metastasis
$602,786Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Leveraging Vulnerabilities Induced by STING Activation in Pancreatic Cancer
$602,783Timothy R Donahue · University Of California Los Angeles · R01 · FY2022 · CA
Harnessing TNFa Signaling To Improve Therapeutic Response In Pancreatic Cancer
$602,576Kian H Lim · Washington University · R01 · FY2025 · CA
Training in Areas Fundamental to Cancer Research
$602,528Ashani T Weeraratna · Johns Hopkins University · T32 · FY2025 · CA
Metabolic control of regulatory T cell functional identity
$602,526Greg M. Delgoffe · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AI
Metabolic control of regulatory T cell functional identity
$602,526Greg M. Delgoffe · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AI
Metabolic control of regulatory T cell functional identity
$602,526Greg M. Delgoffe · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI
Metabolic control of regulatory T cell functional identity
$602,526Greg M. Delgoffe · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AI
Develop Conditionally Armored CAR Macrophage Therapy for Pancreatic Cancer
$602,518Pingping Hou · Rutgers Biomedical And Health Sciences · R01 · FY2023 · CA
VPS72 controls Treg cell stability and adaptation to tumor microenvironment
$602,346Qing-Sheng Mi · Henry Ford Health + Michigan State University Health Sciences · R01 · FY2024 · CA
Mechanisms of breast cancer associated with obesity
$602,173Charlotte Kuperwasser · Tufts University Boston · R01 · FY2015 · CA
Therapeutic Targeting Mitochondrial C1 Metabolism
$602,150Larry H. Matherly · Wayne State University · R01 · FY2023 · CA
Clinically-Relevant Regulatory Networks in the Lung Tumor Microenvironment
$602,006Sylvia Katina Plevritis · Stanford University · U01 · FY2011 · CA
Systemic delivery of siRNA by Nanosac for checkpoint blockade immunotherapy of head and neck squamous cell cancer
$602,006Yoon Yeo · Purdue University · R01 · FY2021 · CA
High-content functional cancer drug testing on micro-cuboidal tumor dissections
$601,999Albert Folch · University Of Washington · R21 · FY2020 · CA
IL-15 and -21 armored GPC3-specific CAR T cells for children with solid tumors
$601,989Andras A. Heczey · Baylor College Of Medicine · R01 · FY2024 · CA
Role of Eya3 in regulating the immune microenvironment to promote breast tumor progression
$601,947Heide L Ford · University Of Colorado Denver · R01 · FY2019 · CA
Mechanisms of resistance to treatment in aggressive prostate cancers
$601,936Adam Sowalsky · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Preclinical development of breakthrough immunotherapy for brain tumors
$601,887Hideho Okada · University Of California, San Francisco · R35 · FY2018 · NS